Terms and Synonyms Searched:
| Terms | Search Results* | Entire Database** |
|---|---|---|
| Synonyms | ||
| mavrilimumab in severe COVID-19 | 1 studies | 1 studies |
| COVID-19 | 5 studies | 8,901 studies |
| COVID | 5 studies | 8,820 studies |
| SARS-CoV-2 | 4 studies | 4,208 studies |
| Coronavirus disease 2019 | 1 studies | 856 studies |
| 2019-nCoV | -- | 140 studies |
| Coronavirus Disease 19 | -- | 110 studies |
| Novel Coronavirus | -- | 443 studies |
| SARS Coronavirus 2 | -- | 29 studies |
| Severe Acute Respiratory Syndrome Coronavirus 2 | -- | 692 studies |
| Wuhan Coronavirus | -- | 4 studies |
| severe | 5 studies | 79,663 studies |
| Grade 3 | -- | 9,616 studies |
| grade high | -- | 5 studies |
| gravi | -- | 2 studies |
| gravies | -- | 1 studies |
| Gravis | -- | 217 studies |
| High grade | -- | 1,980 studies |
| Major | -- | 25,922 studies |
| Score 4 | -- | 426 studies |
| Severely | -- | 3,139 studies |
| mavrilimumab | 5 studies | 12 studies |
| CAM-3001 | 2 studies | 7 studies |
| -- | No studies found |
| * | Number of studies in the search results containing the term or synonym |
| ** | Number of studies in the entire database containing the term or synonym |